Under‐utilized opportunities to optimize medication management in long‐term treatment of schizophrenia
Open accessAbstract
Under-utilized opportunities to optimize medication management in long-term treatment of schizophrenia
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the United States, only 15-28% of patients with schizophrenia receive a LAI.
“In the United States only 15–28% of patients with schizophrenia receive a LAI [30, 31].”
From The role of shared decision-making in improving adherence to pharmacological treatments in patients with schizophrenia: A clinical review (2020) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients
García, S., Martínez‐Cengotitabengoa, M., López-Zurbano, S., Zorrilla, E. P., López‐Mahía, P., Vieta, E., & González-Pinto, A. M. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000523 · Cited by 363 · see citing works
What is the risk‐benefit ratio of long‐term antipsychotic treatment in people with schizophrenia?
Correll, C. U., Rubio, J. M., & Kane, J. M. (2018) · World Psychiatry · doi:10.1002/wps.20516 · Cited by 324 · see citing works
Veijola, J. M., Guo, J. Y., Moilanen, J. S., Jääskeläinen, E., Miettunen, J., Kyllönen, M., Haapea, M., Huhtaniska, S., Alaräisänen, A., Mäki, P. H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101689 · Cited by 111 · see citing works
Self-citationHusa, A. P., Rannikko, I., Moilanen, J. S., Haapea, M., Murray, G. K., Barnett, J. H., Jones, P. B., Isohanni, M. K., Koponen, H., Miettunen, J., et al. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.06.035 · Cited by 89 · see citing works
Self-citationHuhtaniska, S., Jääskeläinen, E., Hirvonen, N., Remes, J. J., Murray, G. K., Veijola, J. M., Isohanni, M. K., & Miettunen, J. (2017) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2574 · Cited by 79 · see citing works
Self-citationMoilanen, J. S., Haapea, M., Miettunen, J., Jääskeläinen, E., Veijola, J. M., Isohanni, M. K., & Koponen, H. (2011) · European Psychiatry · doi:10.1016/j.eurpsy.2011.06.009 · Cited by 66 · see citing works
Self-citationHoward, P. B., El-Mallakh, P. L., Miller, A. L., Rayens, M. K., Bond, G. R., Henderson, K., & Cooley, A. T. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.7.929 · Cited by 21 · see citing works
Use of psychiatric medications in schizophrenia and other psychoses in a general population sample
Nykänen, S., Puska, V., Tolonen, J., Salo, H., Isohanni, M. K., Koponen, H., Pirkola, S. P., Penttilä, M., Haapea, M., Moilanen, J. S., et al. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.11.013 · Cited by 14 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 8
- Correll CU, Rubio JM, Kane JM. World Psychia- try 2018;17:149-60.
- Veijola J, Guo JY, Moilanen JS et al. PLoS One 2014;9:e101689.
- Moilanen J, Haapea M, Miettunen J et al. Eur Psychiatry 2013;28:53-8.
- Husa AP, Rannikko I, Moilanen J et al. Schiz- ophr Res 2014;158:134-41.
- Nyk€ anen S, Puska V, Tolonen J-P et al. Psychia- try Res 2016;235:160-8.
- Howard PB, El-Mallakh P, Miller AL. Psychiatr Serv 2009;60:929-35.
- Huhtaniska S, J€ a€ askel€ ainen E, Hirvonen N et al. Hum Psychopharmacol Clin Exp 2017;32:e2574.
- Garc ıa S, Mart ınez-Cengotitabengoa M, L opez- Zurbano S et al. J Clin Psychopharmacol 2016; 36:355-71. DOI:10.1002/wps.20523 World Psychiatry 17:2 -June 2018 · DOI
Cited by
Sorted by citations
He, H., Liu, Q., Li, N., Guo, L., Gao, F., Bai, L., Gao, F., & Lyu, J. (2020) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796019000891 · Cited by 193 · see citing works
Fiorillo, A., Barlati, S., Bellomo, A., Corrivetti, G., Nicolò, G., Sampogna, G., Stanga, V., Veltro, F., Maina, G., & Vita, A. (2020) · Annals of General Psychiatry · doi:10.1186/s12991-020-00293-4 · Cited by 110 · see citing works
Seppälä, A., Pylvänäinen, J., Lehtiniemi, H., Hirvonen, N., Corripio, I., Koponen, H., Seppälä, J., Ahmed, A. O., Isohanni, M. K., Miettunen, J., et al. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.08.005 · Cited by 37 · see citing works
Self-citationLiu, C.-C., & Takeuchi, H. (2020) · CNS Drugs · doi:10.1007/s40263-019-00682-8 · Cited by 19 · see citing works
Liu, C., Hsieh, M. H., Chien, Y., Liu, C., Lin, Y., Hwang, T., & Hwu, H. (2021) · Early Intervention in Psychiatry · doi:10.1111/eip.13144 · Cited by 11 · see citing works
Yen, K., Liu, C., Lin, Y., Chien, Y., Hsieh, M. H., Liu, C., Hwang, T., Liao, W.-H., & Hwu, H. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s339866 · Cited by 9 · see citing works
Liu, C., Liu, C.-M., Chien, Y., Lin, Y., Hsieh, M. H., Hwang, T., & Hwu, H. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.714878 · Cited by 7 · see citing works
Li, N., Chen, S., Wu, Z., Dong, J., Wang, J., Lei, Y., Mo, J., Wei, W., & Li, T. (2024) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2024.104192 · Cited by 5 · see citing works
Medication management of antipsychotic treatment in schizophrenia—A narrative review
Isohanni, M. K., Jääskeläinen, E., Miller, B. J., Hulkko, A., Tiihonen, J., Möller, H., Hartikainen, S. A., Huhtaniska, S., & Lieslehto, J. (2020) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2765 · Cited by 2 · see citing works
Self-citation
- Authors
- Isohanni, M., Miettunen, J., Jääskeläinen, E., Moilanen, J., Hulkko, A., & Huhtaniska, S.
- Affiliations
- University of Oulu (FI)
- Oulu University Hospital (FI)
- Venue
- World Psychiatry
- Publisher
- Wiley
- Published
- 2018-05-24
- Volume
- 17
- Issue
- 2
- Pages
- 172-173
- ISSN
- 1723-8617 (ISSN-L)
- 2051-5545
- PMC
- PMC5980385
- OpenAlex
- W2807157379
- Cited by
- 9
- References
- 8
- Citations by year
- 2024: 1 · 2022: 1 · 2021: 3 · 2020: 3 · 2019: 1
- FWCI
- 1.37
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- World Psychiatry (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Center Oulu
- Oulun Yliopisto
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- schizophrenia, long-term treatment, medication management, antipsychotic adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
